Year|ICCC Group|Age|Event Type|Age-Adjusted Rate|Age-Adjusted CI Lower|Age-Adjusted CI Upper|Count|Population|ICCC.order
1999|All ICCC Groups Combined|0-14|Incidence|145.2|142.0|148.4|8032|55434108|1
1999|All ICCC Groups Combined|0-19|Incidence|157.8|154.9|160.7|11644|73938842|1
1999|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.6| 43.9| 47.4|2527|55434108|2
1999|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 40.9| 39.4| 42.4|3023|73938842|2
1999|I(a) Lymphoid leukemias|0-14|Incidence| 35.6| 34.0| 37.2|1973|55434108|3
1999|I(a) Lymphoid leukemias|0-19|Incidence| 30.2| 28.9| 31.4|2232|73938842|3
1999|I(b) Acute myeloid leukemias|0-14|Incidence|  7.7|  7.0|  8.4|424|55434108|4
1999|I(b) Acute myeloid leukemias|0-19|Incidence|  8.1|  7.5|  8.8|598|73938842|4
1999|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  0.6|  0.4|  0.9|34|55434108|5
1999|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.0|  0.8|  1.3|74|73938842|5
1999|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|~|~|~|~|55434108|6
1999|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|~|~|~|~|73938842|6
1999|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.6|  1.3|  1.9|87|55434108|7
1999|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.5|  1.2|  1.8|109|73938842|7
1999|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.4| 14.4| 16.5|853|55434108|8
1999|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.1| 22.1| 24.3|1707|73938842|8
1999|II(a) Hodgkin lymphomas|0-14|Incidence|  5.5|  4.9|  6.2|304|55434108|9
1999|II(a) Hodgkin lymphomas|0-19|Incidence| 11.7| 11.0| 12.6|865|73938842|9
1999|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.0|  5.3|  6.6|330|55434108|10
1999|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  7.6|  7.0|  8.3|561|73938842|10
1999|II(c) Burkitt lymphoma|0-14|Incidence|  2.6|  2.2|  3.0|142|55434108|11
1999|II(c) Burkitt lymphoma|0-19|Incidence|  2.4|  2.1|  2.8|180|73938842|11
1999|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.7|  1.3|54|55434108|12
1999|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|56|73938842|12
1999|II(e) Unspecified lymphomas|0-14|Incidence|  0.4|  0.3|  0.6|23|55434108|13
1999|II(e) Unspecified lymphomas|0-19|Incidence|  0.6|  0.4|  0.8|45|73938842|13
1999|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 31.1| 29.7| 32.6|1726|55434108|14
1999|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 28.2| 27.1| 29.5|2091|73938842|14
1999|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.8|  2.4|  3.3|157|55434108|15
1999|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.5|  2.2|  2.9|186|73938842|15
1999|III(b) Astrocytomas|0-14|Incidence| 13.9| 12.9| 14.9|771|55434108|16
1999|III(b) Astrocytomas|0-19|Incidence| 13.2| 12.4| 14.0|975|73938842|16
1999|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  8.0|  7.3|  8.8|443|55434108|17
1999|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.8|  6.2|  7.4|501|73938842|17
1999|III(d) Other gliomas|0-14|Incidence|  5.2|  4.6|  5.8|289|55434108|18
1999|III(d) Other gliomas|0-19|Incidence|  4.7|  4.2|  5.2|348|73938842|18
1999|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|27|55434108|19
1999|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.7|36|73938842|19
1999|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|39|55434108|20
1999|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.6|  0.4|  0.8|45|73938842|20
1999|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.6|  9.8| 11.5|583|55434108|21
1999|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.2|  7.5|  8.9|602|73938842|21
1999|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.4|  9.6| 11.3|575|55434108|22
1999|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.3|  8.6|582|73938842|22
1999|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|55434108|23
1999|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.3|  0.2|  0.4|20|73938842|23
1999|V Retinoblastoma|0-14|Incidence|  4.2|  3.7|  4.8|232|55434108|24
1999|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.6|233|73938842|24
1999|VI Renal tumors|0-14|Incidence|  8.1|  7.4|  8.9|450|55434108|25
1999|VI Renal tumors|0-19|Incidence|  6.5|  5.9|  7.1|477|73938842|25
1999|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.7|  7.0|  8.4|425|55434108|26
1999|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.9|  5.3|  6.5|434|73938842|26
1999|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|22|55434108|27
1999|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|39|73938842|27
1999|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|55434108|28
1999|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|73938842|28
1999|VII Hepatic tumors|0-14|Incidence|  2.1|  1.7|  2.5|114|55434108|29
1999|VII Hepatic tumors|0-19|Incidence|  2.0|  1.7|  2.3|146|73938842|29
1999|VII(a) Hepatoblastoma|0-14|Incidence|  1.7|  1.4|  2.1|93|55434108|30
1999|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.0|  1.6|94|73938842|30
1999|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|21|55434108|31
1999|VII(b) Hepatic carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|51|73938842|31
1999|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|55434108|32
1999|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|73938842|32
1999|VIII Malignant bone tumors|0-14|Incidence|  7.1|  6.4|  7.8|392|55434108|33
1999|VIII Malignant bone tumors|0-19|Incidence|  8.7|  8.1|  9.4|643|73938842|33
1999|VIII(a) Osteosarcomas|0-14|Incidence|  4.2|  3.7|  4.8|233|55434108|34
1999|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.6|  5.6|375|73938842|34
1999|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|55434108|35
1999|VIII(b) Chondrosarcomas|0-19|Incidence|  0.3|  0.2|  0.5|25|73938842|35
1999|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.3|  1.9|  2.8|129|55434108|36
1999|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.7|  2.3|  3.1|199|73938842|36
1999|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|17|55434108|37
1999|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.6|34|73938842|37
1999|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|55434108|38
1999|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|73938842|38
1999|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence|  9.3|  8.5| 10.1|514|55434108|39
1999|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 10.7|  9.9| 11.4|787|73938842|39
1999|IX(a) Rhabdomyosarcomas|0-14|Incidence|  4.8|  4.2|  5.4|264|55434108|40
1999|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.4|  4.0|  4.9|328|73938842|40
1999|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.0|  0.7|  1.3|53|55434108|41
1999|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.1|  0.9|  1.4|83|73938842|41
1999|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|55434108|42
1999|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|73938842|42
1999|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  2.6|  2.1|  3.0|141|55434108|43
1999|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  3.8|  3.4|  4.3|279|73938842|43
1999|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.3|55|55434108|44
1999|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.3|  1.0|  1.6|94|73938842|44
1999|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.0|  4.4|  5.6|275|55434108|45
1999|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.1|  9.4| 10.9|744|73938842|45
1999|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.0|  1.6|72|55434108|46
1999|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|102|73938842|46
1999|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.7|76|55434108|47
1999|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|102|73938842|47
1999|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.1|  1.7|  2.5|116|55434108|48
1999|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|493|73938842|48
1999|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|55434108|49
1999|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.6|32|73938842|49
1999|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|55434108|50
1999|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|~|~|~|~|73938842|50
1999|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  5.9|  5.2|  6.5|323|55434108|51
1999|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 15.2| 14.3| 16.1|1115|73938842|51
1999|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|55434108|52
1999|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|16|73938842|52
1999|XI(b) Thyroid carcinomas|0-14|Incidence|  1.9|  1.6|  2.3|105|55434108|53
1999|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.3|  6.4|429|73938842|53
1999|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.4|  0.3|  0.6|22|55434108|54
1999|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|42|73938842|54
1999|XI(d) Malignant melanomas|0-14|Incidence|  1.7|  1.4|  2.1|95|55434108|55
1999|XI(d) Malignant melanomas|0-19|Incidence|  4.6|  4.1|  5.1|336|73938842|55
1999|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|55434108|56
1999|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|73938842|56
1999|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.6|  1.2|  1.9|86|55434108|57
1999|XI(f) Other and unspecified carcinomas|0-19|Incidence|  3.9|  3.4|  4.4|285|73938842|57
1999|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|26|55434108|58
1999|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|52|73938842|58
1999|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|55434108|59
1999|XII(a) Other specified malignant tumors|0-19|Incidence|~|~|~|~|73938842|59
1999|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|17|55434108|60
1999|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.5|  0.4|  0.7|38|73938842|60
1999|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|17|55434108|61
1999|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.5|24|73938842|61
2000|All ICCC Groups Combined|0-14|Incidence|148.0|144.7|151.2|8063|54602134|1
2000|All ICCC Groups Combined|0-19|Incidence|161.7|158.8|164.7|11777|72922524|1
2000|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.9| 44.1| 47.7|2495|54602134|2
2000|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 41.2| 39.7| 42.7|2997|72922524|2
2000|I(a) Lymphoid leukemias|0-14|Incidence| 37.0| 35.4| 38.6|2011|54602134|3
2000|I(a) Lymphoid leukemias|0-19|Incidence| 31.7| 30.5| 33.1|2307|72922524|3
2000|I(b) Acute myeloid leukemias|0-14|Incidence|  6.5|  5.8|  7.2|354|54602134|4
2000|I(b) Acute myeloid leukemias|0-19|Incidence|  7.0|  6.4|  7.6|510|72922524|4
2000|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  0.8|  0.6|  1.0|42|54602134|5
2000|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  0.9|  0.7|  1.1|65|72922524|5
2000|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|~|~|~|~|54602134|6
2000|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|~|~|~|~|72922524|6
2000|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.5|  1.2|  1.9|82|54602134|7
2000|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.5|  1.2|  1.8|108|72922524|7
2000|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.5| 15.4| 17.6|902|54602134|8
2000|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.7| 23.6| 25.9|1804|72922524|8
2000|II(a) Hodgkin lymphomas|0-14|Incidence|  5.8|  5.2|  6.5|318|54602134|9
2000|II(a) Hodgkin lymphomas|0-19|Incidence| 12.2| 11.4| 13.0|890|72922524|9
2000|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  5.9|  5.2|  6.5|321|54602134|10
2000|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.1|  7.4|  8.8|590|72922524|10
2000|II(c) Burkitt lymphoma|0-14|Incidence|  2.9|  2.4|  3.4|157|54602134|11
2000|II(c) Burkitt lymphoma|0-19|Incidence|  2.7|  2.4|  3.1|200|72922524|11
2000|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.3|  1.1|  1.7|73|54602134|12
2000|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  1.0|  0.8|  1.3|76|72922524|12
2000|II(e) Unspecified lymphomas|0-14|Incidence|  0.6|  0.4|  0.8|33|54602134|13
2000|II(e) Unspecified lymphomas|0-19|Incidence|  0.7|  0.5|  0.9|48|72922524|13
2000|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.6| 31.1| 34.1|1777|54602134|14
2000|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.7| 28.5| 31.0|2164|72922524|14
2000|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.6|  2.2|  3.1|144|54602134|15
2000|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.3|  1.9|  2.7|166|72922524|15
2000|III(b) Astrocytomas|0-14|Incidence| 16.7| 15.6| 17.8|911|54602134|16
2000|III(b) Astrocytomas|0-19|Incidence| 15.4| 14.5| 16.3|1124|72922524|16
2000|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.5|  6.8|  8.3|411|54602134|17
2000|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  5.9|  7.1|471|72922524|17
2000|III(d) Other gliomas|0-14|Incidence|  4.4|  3.9|  5.0|243|54602134|18
2000|III(d) Other gliomas|0-19|Incidence|  4.3|  3.9|  4.8|316|72922524|18
2000|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|28|54602134|19
2000|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.7|36|72922524|19
2000|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|40|54602134|20
2000|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|51|72922524|20
2000|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence|  9.9|  9.0| 10.7|535|54602134|21
2000|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  7.5|  6.9|  8.2|543|72922524|21
2000|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence|  9.8|  8.9| 10.6|529|54602134|22
2000|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.4|  6.8|  8.0|535|72922524|22
2000|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|54602134|23
2000|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|72922524|23
2000|V Retinoblastoma|0-14|Incidence|  4.2|  3.7|  4.8|230|54602134|24
2000|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.6|231|72922524|24
2000|VI Renal tumors|0-14|Incidence|  8.5|  7.7|  9.3|459|54602134|25
2000|VI Renal tumors|0-19|Incidence|  6.6|  6.0|  7.2|478|72922524|25
2000|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.1|  7.3|  8.8|437|54602134|26
2000|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.1|  5.5|  6.7|441|72922524|26
2000|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|21|54602134|27
2000|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|36|72922524|27
2000|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|54602134|28
2000|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|72922524|28
2000|VII Hepatic tumors|0-14|Incidence|  2.1|  1.8|  2.6|116|54602134|29
2000|VII Hepatic tumors|0-19|Incidence|  1.8|  1.5|  2.1|131|72922524|29
2000|VII(a) Hepatoblastoma|0-14|Incidence|  1.9|  1.6|  2.3|104|54602134|30
2000|VII(a) Hepatoblastoma|0-19|Incidence|  1.4|  1.2|  1.7|104|72922524|30
2000|VII(b) Hepatic carcinomas|0-14|Incidence|~|~|~|~|54602134|31
2000|VII(b) Hepatic carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|27|72922524|31
2000|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|54602134|32
2000|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|72922524|32
2000|VIII Malignant bone tumors|0-14|Incidence|  6.6|  5.9|  7.3|362|54602134|33
2000|VIII Malignant bone tumors|0-19|Incidence|  8.4|  7.8|  9.1|614|72922524|33
2000|VIII(a) Osteosarcomas|0-14|Incidence|  3.6|  3.1|  4.2|199|54602134|34
2000|VIII(a) Osteosarcomas|0-19|Incidence|  4.7|  4.2|  5.3|346|72922524|34
2000|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|54602134|35
2000|VIII(b) Chondrosarcomas|0-19|Incidence|~|~|~|~|72922524|35
2000|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.6|  2.2|  3.1|144|54602134|36
2000|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.0|  2.6|  3.5|221|72922524|36
2000|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|54602134|37
2000|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|18|72922524|37
2000|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|54602134|38
2000|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|16|72922524|38
2000|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.4|  9.5| 11.3|566|54602134|39
2000|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.9| 11.1| 12.7|865|72922524|39
2000|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.2|  4.6|  5.8|283|54602134|40
2000|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.8|  4.3|  5.4|351|72922524|40
2000|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  0.9|  0.7|  1.2|51|54602134|41
2000|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.2|  1.0|  1.5|87|72922524|41
2000|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|54602134|42
2000|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|72922524|42
2000|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.1|  2.7|  3.7|172|54602134|43
2000|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.4|  4.0|  5.0|324|72922524|43
2000|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.1|  0.8|  1.4|59|54602134|44
2000|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.4|  1.1|  1.7|99|72922524|44
2000|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.0|  4.4|  5.6|274|54602134|45
2000|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.6|  9.9| 11.4|776|72922524|45
2000|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.8|80|54602134|46
2000|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.7|  1.4|  2.0|123|72922524|46
2000|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.1|  0.8|  1.4|59|54602134|47
2000|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|99|72922524|47
2000|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  1.9|  2.7|124|54602134|48
2000|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.9|  6.3|  7.6|505|72922524|48
2000|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|54602134|49
2000|X(d) Gonadal carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|35|72922524|49
2000|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|54602134|50
2000|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|~|~|~|~|72922524|50
2000|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  5.5|  4.9|  6.2|302|54602134|51
2000|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 15.2| 14.3| 16.1|1110|72922524|51
2000|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|54602134|52
2000|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.3|  0.2|  0.5|22|72922524|52
2000|XI(b) Thyroid carcinomas|0-14|Incidence|  1.8|  1.4|  2.2|97|54602134|53
2000|XI(b) Thyroid carcinomas|0-19|Incidence|  5.5|  4.9|  6.0|399|72922524|53
2000|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|54602134|54
2000|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|41|72922524|54
2000|XI(d) Malignant melanomas|0-14|Incidence|  1.6|  1.3|  2.0|90|54602134|55
2000|XI(d) Malignant melanomas|0-19|Incidence|  4.9|  4.4|  5.4|358|72922524|55
2000|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|54602134|56
2000|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|72922524|56
2000|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.4|  1.1|  1.8|78|54602134|57
2000|XI(f) Other and unspecified carcinomas|0-19|Incidence|  3.9|  3.5|  4.4|284|72922524|57
2000|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|31|54602134|58
2000|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.6|  0.5|  0.8|46|72922524|58
2000|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|54602134|59
2000|XII(a) Other specified malignant tumors|0-19|Incidence|~|~|~|~|72922524|59
2000|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|19|54602134|60
2000|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.6|32|72922524|60
2000|Not classified by ICCC|0-14|Incidence|~|~|~|~|54602134|61
2000|Not classified by ICCC|0-19|Incidence|  0.2|  0.1|  0.4|18|72922524|61
2001|All ICCC Groups Combined|0-14|Incidence|156.0|152.7|159.3|8572|54969405|1
2001|All ICCC Groups Combined|0-19|Incidence|169.7|166.8|172.7|12457|73406436|1
2001|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 50.9| 49.0| 52.8|2786|54969405|2
2001|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 45.9| 44.3| 47.4|3354|73406436|2
2001|I(a) Lymphoid leukemias|0-14|Incidence| 39.1| 37.5| 40.8|2136|54969405|3
2001|I(a) Lymphoid leukemias|0-19|Incidence| 33.4| 32.1| 34.7|2435|73406436|3
2001|I(b) Acute myeloid leukemias|0-14|Incidence|  7.4|  6.7|  8.1|406|54969405|4
2001|I(b) Acute myeloid leukemias|0-19|Incidence|  7.7|  7.1|  8.3|565|73406436|4
2001|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|91|54969405|5
2001|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.1|  1.8|  2.4|154|73406436|5
2001|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.7|  1.3|  2.0|91|54969405|6
2001|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.5|  1.3|  1.8|113|73406436|6
2001|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.1|  0.9|  1.4|62|54969405|7
2001|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  0.9|  1.5|87|73406436|7
2001|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.1| 15.1| 17.2|891|54969405|8
2001|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.7| 23.5| 25.8|1813|73406436|8
2001|II(a) Hodgkin lymphomas|0-14|Incidence|  5.9|  5.3|  6.6|328|54969405|9
2001|II(a) Hodgkin lymphomas|0-19|Incidence| 12.5| 11.7| 13.4|922|73406436|9
2001|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.7|  6.0|  7.4|368|54969405|10
2001|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.8|  8.2|  9.5|648|73406436|10
2001|II(c) Burkitt lymphoma|0-14|Incidence|  2.3|  1.9|  2.7|124|54969405|11
2001|II(c) Burkitt lymphoma|0-19|Incidence|  2.2|  1.8|  2.5|158|73406436|11
2001|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.7|  1.3|53|54969405|12
2001|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.7|  0.5|  1.0|54|73406436|12
2001|II(e) Unspecified lymphomas|0-14|Incidence|  0.3|  0.2|  0.5|18|54969405|13
2001|II(e) Unspecified lymphomas|0-19|Incidence|  0.4|  0.3|  0.6|31|73406436|13
2001|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.3| 30.8| 33.8|1770|54969405|14
2001|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.5| 28.3| 30.8|2166|73406436|14
2001|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.7|  2.3|  3.2|150|54969405|15
2001|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.4|  2.0|  2.8|174|73406436|15
2001|III(b) Astrocytomas|0-14|Incidence| 16.0| 14.9| 17.0|875|54969405|16
2001|III(b) Astrocytomas|0-19|Incidence| 14.7| 13.9| 15.6|1079|73406436|16
2001|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.2|  6.5|  8.0|397|54969405|17
2001|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  6.0|  7.2|479|73406436|17
2001|III(d) Other gliomas|0-14|Incidence|  5.3|  4.7|  6.0|292|54969405|18
2001|III(d) Other gliomas|0-19|Incidence|  4.9|  4.5|  5.5|363|73406436|18
2001|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  0.9|36|54969405|19
2001|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.6|  0.4|  0.8|43|73406436|19
2001|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.6|20|54969405|20
2001|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.6|28|73406436|20
2001|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 11.6| 10.7| 12.6|641|54969405|21
2001|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.9|  8.2|  9.6|654|73406436|21
2001|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 11.5| 10.6| 12.4|635|54969405|22
2001|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.7|  8.1|  9.4|642|73406436|22
2001|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|54969405|23
2001|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|73406436|23
2001|V Retinoblastoma|0-14|Incidence|  4.3|  3.7|  4.8|236|54969405|24
2001|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.6|236|73406436|24
2001|VI Renal tumors|0-14|Incidence|  8.6|  7.8|  9.4|468|54969405|25
2001|VI Renal tumors|0-19|Incidence|  6.8|  6.2|  7.4|493|73406436|25
2001|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.2|  7.4|  9.0|446|54969405|26
2001|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.2|  5.6|  6.8|449|73406436|26
2001|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|20|54969405|27
2001|VI(b) Renal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|42|73406436|27
2001|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|54969405|28
2001|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|73406436|28
2001|VII Hepatic tumors|0-14|Incidence|  2.1|  1.7|  2.5|115|54969405|29
2001|VII Hepatic tumors|0-19|Incidence|  1.8|  1.5|  2.2|134|73406436|29
2001|VII(a) Hepatoblastoma|0-14|Incidence|  1.7|  1.4|  2.1|93|54969405|30
2001|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.0|  1.6|94|73406436|30
2001|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|21|54969405|31
2001|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|39|73406436|31
2001|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|54969405|32
2001|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|73406436|32
2001|VIII Malignant bone tumors|0-14|Incidence|  6.9|  6.2|  7.6|379|54969405|33
2001|VIII Malignant bone tumors|0-19|Incidence|  9.3|  8.6| 10.0|685|73406436|33
2001|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.3|207|54969405|34
2001|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.6|  5.6|375|73406436|34
2001|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|54969405|35
2001|VIII(b) Chondrosarcomas|0-19|Incidence|  0.4|  0.2|  0.5|26|73406436|35
2001|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.7|  2.2|  3.1|147|54969405|36
2001|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.3|  2.9|  3.8|244|73406436|36
2001|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|54969405|37
2001|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.3|  0.6|30|73406436|37
2001|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|54969405|38
2001|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|73406436|38
2001|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.4|  9.6| 11.3|573|54969405|39
2001|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.0| 12.6|866|73406436|39
2001|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.1|  4.5|  5.7|278|54969405|40
2001|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.5|361|73406436|40
2001|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.3|  1.0|  1.6|72|54969405|41
2001|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.5|  1.2|  1.8|109|73406436|41
2001|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|54969405|42
2001|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|73406436|42
2001|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.0|  2.6|  3.5|167|54969405|43
2001|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.1|  3.6|  4.6|301|73406436|43
2001|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.3|56|54969405|44
2001|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|92|73406436|44
2001|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.1|  4.5|  5.7|284|54969405|45
2001|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.5|  9.8| 11.2|772|73406436|45
2001|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.0|  1.6|72|54969405|46
2001|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|119|73406436|46
2001|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|79|54969405|47
2001|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|120|73406436|47
2001|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.1|  1.7|  2.5|116|54969405|48
2001|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|489|73406436|48
2001|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|54969405|49
2001|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.2|  0.5|25|73406436|49
2001|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|54969405|50
2001|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|19|73406436|50
2001|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.8|  6.1|  7.5|378|54969405|51
2001|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 16.4| 15.5| 17.4|1208|73406436|51
2001|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|54969405|52
2001|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|16|73406436|52
2001|XI(b) Thyroid carcinomas|0-14|Incidence|  2.4|  2.0|  2.9|134|54969405|53
2001|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.3|  6.4|427|73406436|53
2001|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|54969405|54
2001|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|43|73406436|54
2001|XI(d) Malignant melanomas|0-14|Incidence|  2.0|  1.6|  2.4|109|54969405|55
2001|XI(d) Malignant melanomas|0-19|Incidence|  5.7|  5.2|  6.3|421|73406436|55
2001|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|54969405|56
2001|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|73406436|56
2001|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.4|  2.2|98|54969405|57
2001|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.6|  4.5|297|73406436|57
2001|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|31|54969405|58
2001|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|50|73406436|58
2001|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.6|21|54969405|59
2001|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.6|28|73406436|59
2001|XII(b) Other unspecified malignant tumors|0-14|Incidence|~|~|~|~|54969405|60
2001|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.5|22|73406436|60
2001|Not classified by ICCC|0-14|Incidence|  0.4|  0.2|  0.6|20|54969405|61
2001|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|26|73406436|61
2002|All ICCC Groups Combined|0-14|Incidence|152.9|149.6|156.1|8609|56272486|1
2002|All ICCC Groups Combined|0-19|Incidence|168.2|165.3|171.2|12645|75147788|1
2002|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 48.7| 46.9| 50.6|2735|56272486|2
2002|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 44.2| 42.7| 45.8|3318|75147788|2
2002|I(a) Lymphoid leukemias|0-14|Incidence| 36.3| 34.8| 38.0|2036|56272486|3
2002|I(a) Lymphoid leukemias|0-19|Incidence| 31.3| 30.0| 32.6|2343|75147788|3
2002|I(b) Acute myeloid leukemias|0-14|Incidence|  7.9|  7.2|  8.7|446|56272486|4
2002|I(b) Acute myeloid leukemias|0-19|Incidence|  8.2|  7.6|  8.9|619|75147788|4
2002|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.5|  1.2|  1.9|86|56272486|5
2002|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.0|  1.7|  2.3|148|75147788|5
2002|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|90|56272486|6
2002|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.5|  1.2|  1.8|113|75147788|6
2002|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.4|  1.1|  1.7|77|56272486|7
2002|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.3|  1.0|  1.5|95|75147788|7
2002|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.5| 14.5| 16.6|878|56272486|8
2002|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.2| 23.1| 25.3|1820|75147788|8
2002|II(a) Hodgkin lymphomas|0-14|Incidence|  5.4|  4.8|  6.0|306|56272486|9
2002|II(a) Hodgkin lymphomas|0-19|Incidence| 12.1| 11.3| 12.9|913|75147788|9
2002|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.2|  5.5|  6.9|348|56272486|10
2002|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.2|  7.6|  8.9|620|75147788|10
2002|II(c) Burkitt lymphoma|0-14|Incidence|  2.7|  2.3|  3.2|152|56272486|11
2002|II(c) Burkitt lymphoma|0-19|Incidence|  2.7|  2.3|  3.1|202|75147788|11
2002|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.1|  0.8|  1.4|60|56272486|12
2002|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|61|75147788|12
2002|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|56272486|13
2002|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.2|  0.5|24|75147788|13
2002|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 33.3| 31.8| 34.8|1868|56272486|14
2002|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 30.3| 29.0| 31.5|2271|75147788|14
2002|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.6|  3.1|  4.1|202|56272486|15
2002|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  3.0|  2.6|  3.4|222|75147788|15
2002|III(b) Astrocytomas|0-14|Incidence| 15.4| 14.4| 16.5|865|56272486|16
2002|III(b) Astrocytomas|0-19|Incidence| 14.5| 13.6| 15.4|1087|75147788|16
2002|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.4|  6.7|  8.1|414|56272486|17
2002|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.4|  5.8|  6.9|476|75147788|17
2002|III(d) Other gliomas|0-14|Incidence|  5.8|  5.2|  6.5|324|56272486|18
2002|III(d) Other gliomas|0-19|Incidence|  5.4|  4.9|  5.9|404|75147788|18
2002|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|41|56272486|19
2002|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  1.0|55|75147788|19
2002|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.6|22|56272486|20
2002|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.2|  0.5|27|75147788|20
2002|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.8| 10.0| 11.7|611|56272486|21
2002|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.3|  7.6|  8.9|624|75147788|21
2002|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.7|  9.9| 11.6|606|56272486|22
2002|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.1|  7.5|  8.7|610|75147788|22
2002|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|56272486|23
2002|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|75147788|23
2002|V Retinoblastoma|0-14|Incidence|  3.7|  3.2|  4.2|210|56272486|24
2002|V Retinoblastoma|0-19|Incidence|  2.8|  2.4|  3.2|210|75147788|24
2002|VI Renal tumors|0-14|Incidence|  8.3|  7.5|  9.0|463|56272486|25
2002|VI Renal tumors|0-19|Incidence|  6.5|  5.9|  7.1|486|75147788|25
2002|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.0|  7.3|  8.8|451|56272486|26
2002|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.1|  5.5|  6.6|454|75147788|26
2002|VI(b) Renal carcinomas|0-14|Incidence|~|~|~|~|56272486|27
2002|VI(b) Renal carcinomas|0-19|Incidence|  0.4|  0.3|  0.6|31|75147788|27
2002|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|56272486|28
2002|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|75147788|28
2002|VII Hepatic tumors|0-14|Incidence|  1.9|  1.5|  2.3|106|56272486|29
2002|VII Hepatic tumors|0-19|Incidence|  1.7|  1.4|  2.0|125|75147788|29
2002|VII(a) Hepatoblastoma|0-14|Incidence|  1.5|  1.2|  1.9|86|56272486|30
2002|VII(a) Hepatoblastoma|0-19|Incidence|  1.2|  0.9|  1.4|87|75147788|30
2002|VII(b) Hepatic carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|56272486|31
2002|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|37|75147788|31
2002|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|56272486|32
2002|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|75147788|32
2002|VIII Malignant bone tumors|0-14|Incidence|  6.8|  6.1|  7.5|385|56272486|33
2002|VIII Malignant bone tumors|0-19|Incidence|  9.0|  8.3|  9.7|678|75147788|33
2002|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.2|209|56272486|34
2002|VIII(a) Osteosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|371|75147788|34
2002|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|56272486|35
2002|VIII(b) Chondrosarcomas|0-19|Incidence|  0.5|  0.3|  0.6|34|75147788|35
2002|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.5|  2.1|  3.0|142|56272486|36
2002|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.0|  2.6|  3.4|225|75147788|36
2002|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.4|  0.2|  0.5|20|56272486|37
2002|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.7|37|75147788|37
2002|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|56272486|38
2002|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|75147788|38
2002|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.9| 10.1| 11.8|615|56272486|39
2002|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.0| 12.6|885|75147788|39
2002|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.4|  4.8|  6.1|304|56272486|40
2002|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.5|369|75147788|40
2002|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.2|  0.9|  1.5|69|56272486|41
2002|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.2|  1.0|  1.5|90|75147788|41
2002|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|56272486|42
2002|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|75147788|42
2002|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.4|  2.9|  3.9|190|56272486|43
2002|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.7|  4.2|  5.2|353|75147788|43
2002|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  0.9|  0.7|  1.2|52|56272486|44
2002|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.0|  0.8|  1.2|73|75147788|44
2002|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.5|  4.9|  6.1|310|56272486|45
2002|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.1| 10.4| 11.9|838|75147788|45
2002|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.9|85|56272486|46
2002|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.7|  1.4|  2.0|128|75147788|46
2002|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.9|86|56272486|47
2002|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|122|75147788|47
2002|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  1.9|  2.7|130|56272486|48
2002|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.3|  6.7|  7.9|546|75147788|48
2002|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|56272486|49
2002|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.2|  0.4|20|75147788|49
2002|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|56272486|50
2002|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|22|75147788|50
2002|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.6|  5.9|  7.3|373|56272486|51
2002|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.3| 16.4| 18.3|1305|75147788|51
2002|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|56272486|52
2002|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|18|75147788|52
2002|XI(b) Thyroid carcinomas|0-14|Incidence|  1.9|  1.6|  2.3|110|56272486|53
2002|XI(b) Thyroid carcinomas|0-19|Incidence|  5.7|  5.1|  6.2|427|75147788|53
2002|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|56272486|54
2002|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.8|48|75147788|54
2002|XI(d) Malignant melanomas|0-14|Incidence|  2.3|  1.9|  2.8|132|56272486|55
2002|XI(d) Malignant melanomas|0-19|Incidence|  6.7|  6.1|  7.3|502|75147788|55
2002|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|56272486|56
2002|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|75147788|56
2002|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.7|  1.4|  2.1|98|56272486|57
2002|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.6|  4.5|302|75147788|57
2002|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.5|  0.4|  0.8|31|56272486|58
2002|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|57|75147788|58
2002|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.5|20|56272486|59
2002|XII(a) Other specified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.6|35|75147788|59
2002|XII(b) Other unspecified malignant tumors|0-14|Incidence|~|~|~|~|56272486|60
2002|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.4|22|75147788|60
2002|Not classified by ICCC|0-14|Incidence|  0.4|  0.3|  0.6|24|56272486|61
2002|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|28|75147788|61
2003|All ICCC Groups Combined|0-14|Incidence|149.2|146.1|152.4|8762|58498239|1
2003|All ICCC Groups Combined|0-19|Incidence|164.4|161.6|167.3|12892|78208042|1
2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 46.8| 45.0| 48.6|2736|58498239|2
2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 42.5| 41.1| 44.0|3324|78208042|2
2003|I(a) Lymphoid leukemias|0-14|Incidence| 35.4| 33.9| 37.0|2066|58498239|3
2003|I(a) Lymphoid leukemias|0-19|Incidence| 30.2| 29.0| 31.5|2358|78208042|3
2003|I(b) Acute myeloid leukemias|0-14|Incidence|  7.3|  6.7|  8.1|433|58498239|4
2003|I(b) Acute myeloid leukemias|0-19|Incidence|  7.6|  7.0|  8.3|599|78208042|4
2003|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.3|  1.0|  1.6|77|58498239|5
2003|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.1|  1.7|  2.4|161|78208042|5
2003|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.7|  1.4|  2.1|102|58498239|6
2003|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.6|  1.3|  1.9|125|78208042|6
2003|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.0|  0.7|  1.3|58|58498239|7
2003|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.0|  0.8|  1.3|81|78208042|7
2003|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.8| 14.8| 16.8|926|58498239|8
2003|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.9| 22.8| 25.0|1874|78208042|8
2003|II(a) Hodgkin lymphomas|0-14|Incidence|  5.7|  5.2|  6.4|339|58498239|9
2003|II(a) Hodgkin lymphomas|0-19|Incidence| 12.3| 11.6| 13.1|968|78208042|9
2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.3|  5.7|  7.0|370|58498239|10
2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.0|  7.4|  8.7|630|78208042|10
2003|II(c) Burkitt lymphoma|0-14|Incidence|  2.6|  2.2|  3.1|152|58498239|11
2003|II(c) Burkitt lymphoma|0-19|Incidence|  2.5|  2.2|  2.9|198|78208042|11
2003|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.7|  1.3|58|58498239|12
2003|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|61|78208042|12
2003|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|58498239|13
2003|II(e) Unspecified lymphomas|0-19|Incidence|  0.2|  0.1|  0.3|17|78208042|13
2003|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 31.8| 30.4| 33.3|1859|58498239|14
2003|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.0| 27.8| 30.2|2268|78208042|14
2003|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.5|  2.1|  2.9|145|58498239|15
2003|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.3|  2.0|  2.6|179|78208042|15
2003|III(b) Astrocytomas|0-14|Incidence| 15.5| 14.5| 16.6|907|58498239|16
2003|III(b) Astrocytomas|0-19|Incidence| 14.5| 13.7| 15.4|1136|78208042|16
2003|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.1|  6.5|  7.9|416|58498239|17
2003|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.0|  5.5|  6.6|471|78208042|17
2003|III(d) Other gliomas|0-14|Incidence|  5.5|  5.0|  6.2|324|58498239|18
2003|III(d) Other gliomas|0-19|Incidence|  5.1|  4.6|  5.6|396|78208042|18
2003|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.8|  0.6|  1.1|46|58498239|19
2003|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|56|78208042|19
2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.5|21|58498239|20
2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.5|30|78208042|20
2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.4|  9.5| 11.2|613|58498239|21
2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  7.9|  7.3|  8.6|627|78208042|21
2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.2|  9.4| 11.1|606|58498239|22
2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.8|  7.2|  8.4|616|78208042|22
2003|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|58498239|23
2003|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|78208042|23
2003|V Retinoblastoma|0-14|Incidence|  3.9|  3.4|  4.4|230|58498239|24
2003|V Retinoblastoma|0-19|Incidence|  2.9|  2.6|  3.3|232|78208042|24
2003|VI Renal tumors|0-14|Incidence|  8.3|  7.6|  9.0|485|58498239|25
2003|VI Renal tumors|0-19|Incidence|  6.5|  5.9|  7.1|508|78208042|25
2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.9|  7.2|  8.6|462|58498239|26
2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.9|  5.4|  6.5|464|78208042|26
2003|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|58498239|27
2003|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|40|78208042|27
2003|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|58498239|28
2003|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|78208042|28
2003|VII Hepatic tumors|0-14|Incidence|  2.5|  2.1|  3.0|150|58498239|29
2003|VII Hepatic tumors|0-19|Incidence|  2.2|  1.8|  2.5|171|78208042|29
2003|VII(a) Hepatoblastoma|0-14|Incidence|  2.1|  1.7|  2.5|122|58498239|30
2003|VII(a) Hepatoblastoma|0-19|Incidence|  1.5|  1.3|  1.8|122|78208042|30
2003|VII(b) Hepatic carcinomas|0-14|Incidence|  0.5|  0.3|  0.7|28|58498239|31
2003|VII(b) Hepatic carcinomas|0-19|Incidence|  0.6|  0.5|  0.8|49|78208042|31
2003|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|58498239|32
2003|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|78208042|32
2003|VIII Malignant bone tumors|0-14|Incidence|  6.7|  6.0|  7.4|395|58498239|33
2003|VIII Malignant bone tumors|0-19|Incidence|  8.6|  8.0|  9.3|678|78208042|33
2003|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.3|  4.3|221|58498239|34
2003|VIII(a) Osteosarcomas|0-19|Incidence|  5.3|  4.8|  5.8|415|78208042|34
2003|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|58498239|35
2003|VIII(b) Chondrosarcomas|0-19|Incidence|  0.2|  0.1|  0.4|19|78208042|35
2003|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.2|  1.9|  2.6|131|58498239|36
2003|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.5|  2.2|  2.9|200|78208042|36
2003|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.4|16|58498239|37
2003|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.3|  0.2|  0.5|26|78208042|37
2003|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|58498239|38
2003|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|18|78208042|38
2003|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.6|  9.8| 11.5|624|58498239|39
2003|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 12.1| 11.4| 12.9|951|78208042|39
2003|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.2|  4.6|  5.8|304|58498239|40
2003|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|384|78208042|40
2003|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.0|  0.7|  1.3|57|58498239|41
2003|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.4|  1.1|  1.6|107|78208042|41
2003|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|58498239|42
2003|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|78208042|42
2003|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.5|  3.0|  4.0|204|58498239|43
2003|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.6|  4.1|  5.1|360|78208042|43
2003|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.7|  1.2|57|58498239|44
2003|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|97|78208042|44
2003|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.1|  4.6|  5.7|305|58498239|45
2003|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.2|  9.5| 11.0|805|78208042|45
2003|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.2|  0.9|  1.5|70|58498239|46
2003|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|109|78208042|46
2003|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.8|88|58498239|47
2003|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.5|  1.2|  1.8|116|78208042|47
2003|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.2|  1.9|  2.6|132|58498239|48
2003|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|527|78208042|48
2003|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|58498239|49
2003|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.2|  0.4|23|78208042|49
2003|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|58498239|50
2003|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.4|  0.3|  0.5|30|78208042|50
2003|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.4|  5.8|  7.1|381|58498239|51
2003|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.2| 16.3| 18.2|1354|78208042|51
2003|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|58498239|52
2003|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|19|78208042|52
2003|XI(b) Thyroid carcinomas|0-14|Incidence|  2.1|  1.7|  2.5|124|58498239|53
2003|XI(b) Thyroid carcinomas|0-19|Incidence|  6.0|  5.5|  6.6|472|78208042|53
2003|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|58498239|54
2003|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|54|78208042|54
2003|XI(d) Malignant melanomas|0-14|Incidence|  2.0|  1.7|  2.4|121|58498239|55
2003|XI(d) Malignant melanomas|0-19|Incidence|  6.0|  5.5|  6.5|470|78208042|55
2003|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|58498239|56
2003|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|78208042|56
2003|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.5|  2.2|109|58498239|57
2003|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.2|  3.8|  4.7|331|78208042|57
2003|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.7|  0.5|  0.9|41|58498239|58
2003|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.9|  0.7|  1.2|74|78208042|58
2003|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|19|58498239|59
2003|XII(a) Other specified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.6|36|78208042|59
2003|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.6|22|58498239|60
2003|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.7|38|78208042|60
2003|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|17|58498239|61
2003|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.5|26|78208042|61
2004|All ICCC Groups Combined|0-14|Incidence|156.3|153.1|159.5|9219|58611711|1
2004|All ICCC Groups Combined|0-19|Incidence|170.7|167.8|173.6|13479|78553706|1
2004|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 50.0| 48.2| 51.9|2944|58611711|2
2004|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 45.2| 43.7| 46.7|3558|78553706|2
2004|I(a) Lymphoid leukemias|0-14|Incidence| 37.9| 36.3| 39.5|2225|58611711|3
2004|I(a) Lymphoid leukemias|0-19|Incidence| 32.5| 31.3| 33.8|2558|78553706|3
2004|I(b) Acute myeloid leukemias|0-14|Incidence|  7.8|  7.1|  8.5|461|58611711|4
2004|I(b) Acute myeloid leukemias|0-19|Incidence|  8.1|  7.5|  8.8|644|78553706|4
2004|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.5|  1.2|  1.8|88|58611711|5
2004|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.9|  1.6|  2.2|150|78553706|5
2004|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.5|  1.2|  1.8|87|58611711|6
2004|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.3|  1.1|  1.6|105|78553706|6
2004|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.4|  1.1|  1.7|83|58611711|7
2004|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.3|  1.0|  1.6|101|78553706|7
2004|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.1| 15.1| 17.2|946|58611711|8
2004|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.0| 22.9| 25.1|1890|78553706|8
2004|II(a) Hodgkin lymphomas|0-14|Incidence|  5.3|  4.7|  5.9|310|58611711|9
2004|II(a) Hodgkin lymphomas|0-19|Incidence| 11.7| 11.0| 12.5|929|78553706|9
2004|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.9|  6.3|  7.6|406|58611711|10
2004|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.5|  7.9|  9.2|668|78553706|10
2004|II(c) Burkitt lymphoma|0-14|Incidence|  2.5|  2.1|  2.9|144|58611711|11
2004|II(c) Burkitt lymphoma|0-19|Incidence|  2.4|  2.1|  2.8|187|78553706|11
2004|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.2|  0.9|  1.5|70|58611711|12
2004|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.9|  0.7|  1.2|75|78553706|12
2004|II(e) Unspecified lymphomas|0-14|Incidence|  0.3|  0.2|  0.4|16|58611711|13
2004|II(e) Unspecified lymphomas|0-19|Incidence|  0.4|  0.3|  0.6|31|78553706|13
2004|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 33.0| 31.6| 34.5|1935|58611711|14
2004|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 30.4| 29.2| 31.7|2388|78553706|14
2004|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.0|  2.6|  3.5|176|58611711|15
2004|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.7|  2.4|  3.1|215|78553706|15
2004|III(b) Astrocytomas|0-14|Incidence| 15.9| 14.9| 17.0|932|58611711|16
2004|III(b) Astrocytomas|0-19|Incidence| 15.2| 14.3| 16.1|1193|78553706|16
2004|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.6|  6.9|  8.3|446|58611711|17
2004|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  5.9|  7.0|507|78553706|17
2004|III(d) Other gliomas|0-14|Incidence|  5.2|  4.6|  5.8|301|58611711|18
2004|III(d) Other gliomas|0-19|Incidence|  4.8|  4.4|  5.4|378|78553706|18
2004|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.8|  0.6|  1.1|49|58611711|19
2004|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  0.9|58|78553706|19
2004|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.5|  0.4|  0.7|31|58611711|20
2004|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.6|37|78553706|20
2004|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.9| 10.1| 11.8|655|58611711|21
2004|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.4|  7.8|  9.0|671|78553706|21
2004|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.7|  9.9| 11.6|642|58611711|22
2004|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.1|  7.5|  8.8|650|78553706|22
2004|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|58611711|23
2004|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.3|  0.2|  0.4|21|78553706|23
2004|V Retinoblastoma|0-14|Incidence|  4.2|  3.7|  4.7|251|58611711|24
2004|V Retinoblastoma|0-19|Incidence|  3.1|  2.7|  3.5|251|78553706|24
2004|VI Renal tumors|0-14|Incidence|  7.9|  7.2|  8.6|467|58611711|25
2004|VI Renal tumors|0-19|Incidence|  6.3|  5.8|  6.9|498|78553706|25
2004|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.6|  6.9|  8.3|447|58611711|26
2004|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.8|  5.2|  6.3|455|78553706|26
2004|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|58611711|27
2004|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|42|78553706|27
2004|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|58611711|28
2004|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|78553706|28
2004|VII Hepatic tumors|0-14|Incidence|  2.7|  2.3|  3.1|160|58611711|29
2004|VII Hepatic tumors|0-19|Incidence|  2.4|  2.0|  2.7|190|78553706|29
2004|VII(a) Hepatoblastoma|0-14|Incidence|  2.3|  2.0|  2.8|141|58611711|30
2004|VII(a) Hepatoblastoma|0-19|Incidence|  1.8|  1.5|  2.1|141|78553706|30
2004|VII(b) Hepatic carcinomas|0-14|Incidence|~|~|~|~|58611711|31
2004|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|43|78553706|31
2004|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|58611711|32
2004|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|78553706|32
2004|VIII Malignant bone tumors|0-14|Incidence|  7.0|  6.4|  7.7|413|58611711|33
2004|VIII Malignant bone tumors|0-19|Incidence|  8.9|  8.3|  9.6|703|78553706|33
2004|VIII(a) Osteosarcomas|0-14|Incidence|  4.1|  3.6|  4.7|243|58611711|34
2004|VIII(a) Osteosarcomas|0-19|Incidence|  5.2|  4.7|  5.7|407|78553706|34
2004|VIII(b) Chondrosarcomas|0-14|Incidence|  0.3|  0.2|  0.4|16|58611711|35
2004|VIII(b) Chondrosarcomas|0-19|Incidence|  0.5|  0.4|  0.7|39|78553706|35
2004|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.3|  1.9|  2.7|133|58611711|36
2004|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.7|  2.3|  3.0|210|78553706|36
2004|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|17|58611711|37
2004|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.6|37|78553706|37
2004|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|58611711|38
2004|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|78553706|38
2004|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.4|  9.6| 11.3|614|58611711|39
2004|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.1| 12.6|935|78553706|39
2004|IX(a) Rhabdomyosarcomas|0-14|Incidence|  4.7|  4.1|  5.2|274|58611711|40
2004|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.3|  3.9|  4.8|341|78553706|40
2004|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.2|  0.9|  1.5|72|58611711|41
2004|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.3|  1.0|  1.6|102|78553706|41
2004|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|58611711|42
2004|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|78553706|42
2004|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.5|  3.0|  4.0|207|58611711|43
2004|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  5.0|  4.5|  5.5|394|78553706|43
2004|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.3|60|58611711|44
2004|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|95|78553706|44
2004|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.7|  5.1|  6.3|339|58611711|45
2004|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.2| 10.5| 12.0|889|78553706|45
2004|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.6|  1.3|  1.9|94|58611711|46
2004|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.8|  1.5|  2.1|143|78553706|46
2004|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.3|  1.0|  1.6|79|58611711|47
2004|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.3|  1.0|  1.6|103|78553706|47
2004|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.5|  2.1|  2.9|149|58611711|48
2004|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.4|  6.8|  8.1|589|78553706|48
2004|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|58611711|49
2004|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.6|31|78553706|49
2004|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|58611711|50
2004|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|23|78553706|50
2004|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  7.4|  6.8|  8.2|439|58611711|51
2004|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 18.0| 17.0| 18.9|1421|78553706|51
2004|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|58611711|52
2004|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.3|17|78553706|52
2004|XI(b) Thyroid carcinomas|0-14|Incidence|  2.5|  2.1|  3.0|148|58611711|53
2004|XI(b) Thyroid carcinomas|0-19|Incidence|  6.6|  6.1|  7.2|525|78553706|53
2004|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|23|58611711|54
2004|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.7|44|78553706|54
2004|XI(d) Malignant melanomas|0-14|Incidence|  2.6|  2.2|  3.0|153|58611711|55
2004|XI(d) Malignant melanomas|0-19|Incidence|  6.6|  6.0|  7.2|521|78553706|55
2004|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|58611711|56
2004|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|78553706|56
2004|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.6|  1.3|  1.9|93|58611711|57
2004|XI(f) Other and unspecified carcinomas|0-19|Incidence|  3.9|  3.4|  4.3|305|78553706|57
2004|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|36|58611711|58
2004|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|55|78553706|58
2004|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|19|58611711|59
2004|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.2|  0.5|29|78553706|59
2004|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|17|58611711|60
2004|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.5|26|78553706|60
2004|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|20|58611711|61
2004|Not classified by ICCC|0-19|Incidence|  0.4|  0.3|  0.5|30|78553706|61
2005|All ICCC Groups Combined|0-14|Incidence|148.4|145.3|151.5|8765|58549496|1
2005|All ICCC Groups Combined|0-19|Incidence|165.4|162.5|168.2|13137|78808728|1
2005|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 47.1| 45.3| 48.8|2783|58549496|2
2005|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 42.7| 41.2| 44.1|3381|78808728|2
2005|I(a) Lymphoid leukemias|0-14|Incidence| 36.0| 34.5| 37.6|2129|58549496|3
2005|I(a) Lymphoid leukemias|0-19|Incidence| 31.0| 29.8| 32.2|2450|78808728|3
2005|I(b) Acute myeloid leukemias|0-14|Incidence|  6.9|  6.3|  7.6|410|58549496|4
2005|I(b) Acute myeloid leukemias|0-19|Incidence|  7.3|  6.7|  7.9|578|78808728|4
2005|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.3|  1.0|  1.6|77|58549496|5
2005|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.7|  1.4|  2.0|137|78808728|5
2005|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.4|  1.1|  1.8|84|58549496|6
2005|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.4|  1.1|  1.7|109|78808728|6
2005|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.4|  1.1|  1.7|83|58549496|7
2005|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.3|  1.1|  1.6|107|78808728|7
2005|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.2| 15.2| 17.3|949|58549496|8
2005|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 25.2| 24.2| 26.4|2005|78808728|8
2005|II(a) Hodgkin lymphomas|0-14|Incidence|  5.8|  5.2|  6.5|340|58549496|9
2005|II(a) Hodgkin lymphomas|0-19|Incidence| 12.6| 11.8| 13.4|1001|78808728|9
2005|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.3|  5.7|  7.0|371|58549496|10
2005|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.9|  8.2|  9.5|702|78808728|10
2005|II(c) Burkitt lymphoma|0-14|Incidence|  2.5|  2.1|  3.0|147|58549496|11
2005|II(c) Burkitt lymphoma|0-19|Incidence|  2.4|  2.1|  2.8|191|78808728|11
2005|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.3|  1.1|  1.7|80|58549496|12
2005|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  1.1|  0.9|  1.3|86|78808728|12
2005|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|58549496|13
2005|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.2|  0.5|25|78808728|13
2005|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 30.6| 29.2| 32.0|1791|58549496|14
2005|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 28.2| 27.0| 29.4|2217|78808728|14
2005|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.1|  2.6|  3.5|181|58549496|15
2005|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.8|  2.4|  3.1|218|78808728|15
2005|III(b) Astrocytomas|0-14|Incidence| 15.0| 14.0| 16.0|878|58549496|16
2005|III(b) Astrocytomas|0-19|Incidence| 14.1| 13.3| 14.9|1108|78808728|16
2005|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  6.8|  6.1|  7.5|397|58549496|17
2005|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  5.7|  5.2|  6.3|451|78808728|17
2005|III(d) Other gliomas|0-14|Incidence|  4.7|  4.1|  5.3|273|58549496|18
2005|III(d) Other gliomas|0-19|Incidence|  4.5|  4.0|  5.0|353|78808728|18
2005|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.6|  0.4|  0.9|36|58549496|19
2005|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.6|  0.5|  0.8|50|78808728|19
2005|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.3|  0.6|26|58549496|20
2005|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.6|37|78808728|20
2005|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 11.2| 10.3| 12.0|674|58549496|21
2005|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.5|  7.9|  9.2|688|78808728|21
2005|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 11.0| 10.2| 11.9|667|58549496|22
2005|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.4|  7.8|  9.0|676|78808728|22
2005|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|58549496|23
2005|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|78808728|23
2005|V Retinoblastoma|0-14|Incidence|  3.5|  3.1|  4.0|214|58549496|24
2005|V Retinoblastoma|0-19|Incidence|  2.7|  2.3|  3.0|216|78808728|24
2005|VI Renal tumors|0-14|Incidence|  7.8|  7.1|  8.6|468|58549496|25
2005|VI Renal tumors|0-19|Incidence|  6.3|  5.8|  6.9|506|78808728|25
2005|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.4|  6.8|  8.2|444|58549496|26
2005|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.7|  5.2|  6.3|458|78808728|26
2005|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|20|58549496|27
2005|VI(b) Renal carcinomas|0-19|Incidence|  0.6|  0.4|  0.7|44|78808728|27
2005|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|58549496|28
2005|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|78808728|28
2005|VII Hepatic tumors|0-14|Incidence|  2.3|  1.9|  2.7|137|58549496|29
2005|VII Hepatic tumors|0-19|Incidence|  1.9|  1.6|  2.3|156|78808728|29
2005|VII(a) Hepatoblastoma|0-14|Incidence|  1.8|  1.4|  2.1|107|58549496|30
2005|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.1|  1.6|108|78808728|30
2005|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.3|  0.6|26|58549496|31
2005|VII(b) Hepatic carcinomas|0-19|Incidence|  0.6|  0.4|  0.7|44|78808728|31
2005|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|58549496|32
2005|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|78808728|32
2005|VIII Malignant bone tumors|0-14|Incidence|  6.5|  5.9|  7.2|381|58549496|33
2005|VIII Malignant bone tumors|0-19|Incidence|  8.5|  7.9|  9.2|670|78808728|33
2005|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.2|213|58549496|34
2005|VIII(a) Osteosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|384|78808728|34
2005|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|58549496|35
2005|VIII(b) Chondrosarcomas|0-19|Incidence|  0.2|  0.1|  0.4|19|78808728|35
2005|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.3|  1.9|  2.7|135|58549496|36
2005|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.8|  2.5|  3.2|223|78808728|36
2005|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|18|58549496|37
2005|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.3|  0.6|34|78808728|37
2005|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|58549496|38
2005|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|78808728|38
2005|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.1|  9.3| 11.0|596|58549496|39
2005|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.9| 11.2| 12.7|943|78808728|39
2005|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.1|  4.6|  5.7|301|58549496|40
2005|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.7|  4.3|  5.3|374|78808728|40
2005|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.1|  0.8|  1.3|62|58549496|41
2005|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.3|  1.1|  1.6|105|78808728|41
2005|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|58549496|42
2005|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|78808728|42
2005|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.1|  2.7|  3.6|184|58549496|43
2005|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.7|  4.3|  5.2|377|78808728|43
2005|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  0.8|  0.6|  1.1|46|58549496|44
2005|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.1|  0.8|  1.3|83|78808728|44
2005|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.4|  4.8|  6.0|322|58549496|45
2005|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.2| 10.5| 12.0|898|78808728|45
2005|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.1|  1.7|79|58549496|46
2005|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|123|78808728|46
2005|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.9|94|58549496|47
2005|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.5|  1.3|  1.8|126|78808728|47
2005|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  1.9|  2.7|134|58549496|48
2005|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.4|  6.8|  8.1|596|78808728|48
2005|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|58549496|49
2005|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.5|31|78808728|49
2005|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|58549496|50
2005|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|22|78808728|50
2005|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.8|  6.1|  7.5|397|58549496|51
2005|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.1| 16.2| 18.0|1367|78808728|51
2005|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|58549496|52
2005|XI(a) Adrenocortical carcinomas|0-19|Incidence|~|~|~|~|78808728|52
2005|XI(b) Thyroid carcinomas|0-14|Incidence|  2.1|  1.8|  2.5|125|58549496|53
2005|XI(b) Thyroid carcinomas|0-19|Incidence|  6.1|  5.6|  6.7|489|78808728|53
2005|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|58549496|54
2005|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.4|  0.3|  0.5|30|78808728|54
2005|XI(d) Malignant melanomas|0-14|Incidence|  2.4|  2.0|  2.8|140|58549496|55
2005|XI(d) Malignant melanomas|0-19|Incidence|  6.3|  5.7|  6.9|502|78808728|55
2005|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|58549496|56
2005|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|78808728|56
2005|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.9|  1.6|  2.3|111|58549496|57
2005|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.1|  3.7|  4.6|329|78808728|57
2005|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.5|  0.4|  0.8|32|58549496|58
2005|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|62|78808728|58
2005|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|58549496|59
2005|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.2|  0.5|28|78808728|59
2005|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|17|58549496|60
2005|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.6|34|78808728|60
2005|Not classified by ICCC|0-14|Incidence|  0.4|  0.2|  0.5|21|58549496|61
2005|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|28|78808728|61
2001-2005|All ICCC Groups Combined|0-14|Incidence|153.2|151.7|154.6|42433|275903683|1
2001-2005|All ICCC Groups Combined|0-19|Incidence|168.4|167.1|169.8|62422|369374379|1
2001-2005|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 48.9| 48.0| 49.7|13503|275903683|2
2001-2005|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 44.3| 43.6| 45.0|16368|369374379|2
2001-2005|I(a) Lymphoid leukemias|0-14|Incidence| 37.1| 36.4| 37.8|10235|275903683|3
2001-2005|I(a) Lymphoid leukemias|0-19|Incidence| 31.8| 31.3| 32.4|11739|369374379|3
2001-2005|I(b) Acute myeloid leukemias|0-14|Incidence|  7.5|  7.2|  7.8|2086|275903683|4
2001-2005|I(b) Acute myeloid leukemias|0-19|Incidence|  7.8|  7.6|  8.1|2911|369374379|4
2001-2005|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.5|  1.3|  1.6|407|275903683|5
2001-2005|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.0|  1.8|  2.1|735|369374379|5
2001-2005|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.5|  1.4|  1.7|427|275903683|6
2001-2005|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.4|  1.3|  1.6|534|369374379|6
2001-2005|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.3|  1.1|  1.4|348|275903683|7
2001-2005|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  1.1|  1.3|449|369374379|7
2001-2005|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.0| 15.6| 16.5|4437|275903683|8
2001-2005|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.5| 24.0| 25.0|9070|369374379|8
2001-2005|II(a) Hodgkin lymphomas|0-14|Incidence|  5.6|  5.3|  5.9|1560|275903683|9
2001-2005|II(a) Hodgkin lymphomas|0-19|Incidence| 12.2| 11.9| 12.6|4544|369374379|9
2001-2005|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.5|  6.2|  6.8|1806|275903683|10
2001-2005|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.6|  8.3|  8.9|3165|369374379|10
2001-2005|II(c) Burkitt lymphoma|0-14|Incidence|  2.5|  2.3|  2.7|695|275903683|11
2001-2005|II(c) Burkitt lymphoma|0-19|Incidence|  2.5|  2.3|  2.6|907|369374379|11
2001-2005|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.1|  1.0|  1.3|315|275903683|12
2001-2005|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.9|  0.8|  1.0|331|369374379|12
2001-2005|II(e) Unspecified lymphomas|0-14|Incidence|  0.2|  0.2|  0.3|61|275903683|13
2001-2005|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.3|  0.4|123|369374379|13
2001-2005|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.4| 31.7| 33.1|8935|275903683|14
2001-2005|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.7| 29.2| 30.3|10957|369374379|14
2001-2005|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.0|  2.8|  3.2|821|275903683|15
2001-2005|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.6|  2.5|  2.8|970|369374379|15
2001-2005|III(b) Astrocytomas|0-14|Incidence| 15.7| 15.2| 16.1|4320|275903683|16
2001-2005|III(b) Astrocytomas|0-19|Incidence| 14.7| 14.3| 15.1|5429|369374379|16
2001-2005|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.3|  7.0|  7.6|2009|275903683|17
2001-2005|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.3|  6.0|  6.5|2308|369374379|17
2001-2005|III(d) Other gliomas|0-14|Incidence|  5.4|  5.1|  5.6|1473|275903683|18
2001-2005|III(d) Other gliomas|0-19|Incidence|  5.0|  4.8|  5.2|1845|369374379|18
2001-2005|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.7|  0.6|  0.8|198|275903683|19
2001-2005|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  0.8|252|369374379|19
2001-2005|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.3|  0.5|114|275903683|20
2001-2005|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.5|153|369374379|20
2001-2005|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 11.0| 10.6| 11.4|3077|275903683|21
2001-2005|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.4|  8.1|  8.7|3143|369374379|21
2001-2005|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.9| 10.5| 11.2|3039|275903683|22
2001-2005|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.2|  7.9|  8.5|3074|369374379|22
2001-2005|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|  0.1|  0.1|  0.2|38|275903683|23
2001-2005|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.2|  0.1|  0.2|69|369374379|23
2001-2005|V Retinoblastoma|0-14|Incidence|  4.0|  3.7|  4.2|1113|275903683|24
2001-2005|V Retinoblastoma|0-19|Incidence|  3.0|  2.8|  3.2|1117|369374379|24
2001-2005|VI Renal tumors|0-14|Incidence|  8.2|  7.8|  8.5|2265|275903683|25
2001-2005|VI Renal tumors|0-19|Incidence|  6.5|  6.2|  6.7|2396|369374379|25
2001-2005|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.8|  7.5|  8.2|2171|275903683|26
2001-2005|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.9|  5.7|  6.2|2198|369374379|26
2001-2005|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.4|82|275903683|27
2001-2005|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.6|186|369374379|27
2001-2005|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|275903683|28
2001-2005|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|369374379|28
2001-2005|VII Hepatic tumors|0-14|Incidence|  2.3|  2.1|  2.5|649|275903683|29
2001-2005|VII Hepatic tumors|0-19|Incidence|  2.0|  1.9|  2.2|752|369374379|29
2001-2005|VII(a) Hepatoblastoma|0-14|Incidence|  1.9|  1.7|  2.1|532|275903683|30
2001-2005|VII(a) Hepatoblastoma|0-19|Incidence|  1.4|  1.3|  1.6|535|369374379|30
2001-2005|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.3|  0.5|105|275903683|31
2001-2005|VII(b) Hepatic carcinomas|0-19|Incidence|  0.6|  0.5|  0.6|205|369374379|31
2001-2005|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|275903683|32
2001-2005|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|369374379|32
2001-2005|VIII Malignant bone tumors|0-14|Incidence|  6.8|  6.5|  7.1|1882|275903683|33
2001-2005|VIII Malignant bone tumors|0-19|Incidence|  8.9|  8.6|  9.2|3296|369374379|33
2001-2005|VIII(a) Osteosarcomas|0-14|Incidence|  3.8|  3.6|  4.0|1053|275903683|34
2001-2005|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.8|  5.3|1877|369374379|34
2001-2005|VIII(b) Chondrosarcomas|0-14|Incidence|  0.2|  0.1|  0.2|49|275903683|35
2001-2005|VIII(b) Chondrosarcomas|0-19|Incidence|  0.4|  0.3|  0.4|136|369374379|35
2001-2005|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.4|  2.2|  2.6|665|275903683|36
2001-2005|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.9|  2.7|  3.1|1070|369374379|36
2001-2005|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.4|80|275903683|37
2001-2005|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.4|  0.5|161|369374379|37
2001-2005|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|  0.1|  0.1|  0.2|35|275903683|38
2001-2005|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.1|  0.1|  0.2|52|369374379|38
2001-2005|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.5| 10.1| 10.8|2898|275903683|39
2001-2005|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.9| 11.6| 12.3|4412|369374379|39
2001-2005|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.1|  4.8|  5.4|1402|275903683|40
2001-2005|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.8|  4.6|  5.0|1763|369374379|40
2001-2005|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.1|  1.0|  1.3|316|275903683|41
2001-2005|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.3|  1.2|  1.4|493|369374379|41
2001-2005|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|275903683|42
2001-2005|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|369374379|42
2001-2005|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.3|  3.1|  3.5|915|275903683|43
2001-2005|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.6|  4.4|  4.9|1725|369374379|43
2001-2005|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  0.9|  0.8|  1.1|259|275903683|44
2001-2005|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.1|  1.0|  1.2|418|369374379|44
2001-2005|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.4|  5.2|  5.7|1519|275903683|45
2001-2005|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.0| 10.7| 11.3|4095|369374379|45
2001-2005|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.4|  1.3|  1.5|386|275903683|46
2001-2005|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.5|  1.8|606|369374379|46
2001-2005|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.3|  1.6|416|275903683|47
2001-2005|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.5|  1.4|  1.7|574|369374379|47
2001-2005|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  2.1|  2.5|647|275903683|48
2001-2005|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.2|  6.9|  7.5|2675|369374379|48
2001-2005|X(d) Gonadal carcinomas|0-14|Incidence|  0.1|  0.1|  0.1|29|275903683|49
2001-2005|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.3|  0.4|128|369374379|49
2001-2005|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|  0.1|  0.1|  0.2|41|275903683|50
2001-2005|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|112|369374379|50
2001-2005|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.8|  6.5|  7.1|1897|275903683|51
2001-2005|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.2| 16.8| 17.7|6404|369374379|51
2001-2005|XI(a) Adrenocortical carcinomas|0-14|Incidence|  0.2|  0.2|  0.3|63|275903683|52
2001-2005|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.2|  0.3|79|369374379|52
2001-2005|XI(b) Thyroid carcinomas|0-14|Incidence|  2.2|  2.1|  2.4|620|275903683|53
2001-2005|XI(b) Thyroid carcinomas|0-19|Incidence|  6.1|  5.8|  6.3|2256|369374379|53
2001-2005|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.3|77|275903683|54
2001-2005|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.6|211|369374379|54
2001-2005|XI(d) Malignant melanomas|0-14|Incidence|  2.2|  2.1|  2.4|624|275903683|55
2001-2005|XI(d) Malignant melanomas|0-19|Incidence|  6.2|  6.0|  6.5|2318|369374379|55
2001-2005|XI(e) Skin carcinomas|0-14|Incidence|  0.1|  0.0|  0.1|20|275903683|56
2001-2005|XI(e) Skin carcinomas|0-19|Incidence|  0.1|  0.1|  0.1|33|369374379|56
2001-2005|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.6|  1.9|493|275903683|57
2001-2005|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.1|  3.9|  4.3|1507|369374379|57
2001-2005|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.5|  0.7|161|275903683|58
2001-2005|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.7|  0.8|279|369374379|58
2001-2005|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.3|  0.4|91|275903683|59
2001-2005|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.5|149|369374379|59
2001-2005|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.3|70|275903683|60
2001-2005|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.3|  0.4|130|369374379|60
2001-2005|Not classified by ICCC|0-14|Incidence|  0.3|  0.3|  0.4|97|275903683|61
2001-2005|Not classified by ICCC|0-19|Incidence|  0.4|  0.3|  0.4|133|369374379|61
